New Antiviral Compounds
Tech ID: 23040 / UC Case 2013-137-0
Technology Description
Researchers at UCSD have synthesized a number of new nucleoside compounds that may have advantages in certain antiviral and anticancer indications. These compounds are new acyclic nucleoside phosphonates that may have less toxicity than traditional nucleoside compounds.
State Of Development
Synthetic work on a variety of representative compounds has been done and is ongoing.
Cellular assays are being performed for comparative evaluation and against nucleosides of known activity.
Intellectual Property Info
A provisional patent is being filed.
Patent Status
| Country | Type | Number | Dated | Case |
| United States Of America | Issued Patent | 10,449,207 | 10/22/2019 | 2013-137 |
| United States Of America | Issued Patent | 10,195,222 | 02/05/2019 | 2013-137 |
| United States Of America | Issued Patent | 10,076,532 | 09/18/2018 | 2013-137 |
| United States Of America | Issued Patent | 10,076,533 | 09/18/2018 | 2013-137 |
| United States Of America | Issued Patent | 9,775,852 | 10/03/2017 | 2013-137 |
| United States Of America | Issued Patent | 9,629,860 | 04/25/2017 | 2013-137 |
| United States Of America | Issued Patent | 9,387,217 | 07/12/2016 | 2013-137 |
| United States Of America | Issued Patent | 9,156,867 | 10/13/2015 | 2013-137 |
| United States Of America | Issued Patent | 8,835,630 | 09/16/2014 | 2013-137 |
| United States Of America | Published Application | 20190388442 | 12/26/2019 | 2013-137 |
Contact
- University of California, San Diego Office of Innovation and Commercialization
- innovation@ucsd.edu
- tel: View Phone Number.
